Hematology TimesVariations in blood cancer survival across EuropeSeptember 28, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Hematology TimesFirst-line BV can produce high response rate in older HL patientsSeptember 22, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology TimesBlood cancer drugs set to be removed from CDFSeptember 9, 2015AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyALLMyelodysplastic Syndrome
Hematology TimesFDA approves brentuximab vedotin as consolidationAugust 19, 2015Lymphoma & Plasma Cell DisordersPharmacyTransplantationHodgkin Lymphoma
Hematology NewsInterim PET results guide ongoing therapy in Hodgkin lymphomaJuly 8, 2015Indolent LymphomaHodgkin Lymphoma
Hematology TimesNovel mAb targeting CD70 shows activity in TCLJuly 8, 2015Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesTeam endorses intensified chemo for PET-positive HLJune 30, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology Times‘Radically different’ PI3Kδ inhibitor lacks hepatotoxicityJune 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesNivolumab produces ‘dramatic’ responses in HLJune 25, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Hematology TimesBleomycin can be safely omitted after negative PET2 in HLJune 23, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology NewsAlisertib shows activity in non-Hodgkin lymphomaJune 22, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology TimesPrenatal test can detect lymphoma in mothersJune 8, 2015Lymphoma & Plasma Cell DisordersHodgkin LymphomaFollicular Lymphoma
Hematology TimesHodgkin lymphoma incidence on the decline worldwideMay 29, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaNon-Hodgkin Lymphoma
Hematology TimesCAR T-cell therapy appears feasible in HLMay 28, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Hematology TimesSymptoms confer higher-than-expected risk of HL, NHLMay 1, 2015Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin Lymphoma
